Lincoln Pharmaceuticals (BOM:531633) 3-Year Book Growth Rate : 17.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals 3-Year Book Growth Rate?

Lincoln Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Lincoln Pharmaceuticals's average Book Value per Share Growth Rate was 16.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 17.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 15.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Lincoln Pharmaceuticals was 21.10% per year. The lowest was 1.10% per year. And the median was 16.85% per year.

Competitive Comparison of Lincoln Pharmaceuticals's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lincoln Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's 3-Year Book Growth Rate falls into.

Lincoln Pharmaceuticals 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Lincoln Pharmaceuticals (BOM:531633) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Lincoln Pharmaceuticals 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Lincoln Pharmaceuticals (BOM:531633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

LINCOLN:India

Address

Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060

Website

https://www.lincolnpharma.com

Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals (BOM:531633) Headlines

No Headlines